Filter your search
Drug Delivery Market ReportsX
Kalorama has the information you need on the drug delivery market, including the needle-free systems, transdermal and transmucosal, and infusion pump segments. Our studies describe the market opportunity, the connection to other medical care channels, and the future direction of the market and its segments. Whether you seek market information for dispensing drugs through intra-arterial, intravenous, subcutaneous, epidural, needle-free jet injector, or other methods, Kalorama has the industry intelligence you need.
- $2,200.00 – $5,990.00Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the traditional injection is still the dominant paradigm. However, the staggering costs and intransigent safety problems associated with sharps, […]February 18, 2006$3,500.00 – $7,000.00The market for pain management products is growing at a brisk pace, with some segments moving ahead at over 20%. The future for specialized pharmaceutical and medical device products in this market is bright and new opportunities exist for emerging treatment modalities as well. The report presents the most up-to-date information about the top-producing pain […]November 1, 2004$746.00 – $1,492.00Over the past three years, Kalorama Information’s analysts have studied drug delivery markets from several angles. In 2001 and 2002, we published a 5-volume series on drug delivery technology, each volume devoted to a route of administration: Volume I: Oral Drug Delivery Volume II: Injectable and Implantable Drug Delivery Volume III: Pulmonary Drug Delivery Volume […]November 7, 2003$2,625.00 – $5,250.00Drug delivery technologies continue to be a vital piece of the pharmaceutical marketing puzzle. From clinical efficacy to product differentiation and life-cycle management, delivery technologies are increasingly demanding the attention of developers at earlier and earlier stages. In Kalorama’s 2001-2002 Drug Delivery series, we focused on the markets by route of administration—oral, injectable, implantable, pulmonary, […]July 18, 2003$2,062.00 – $4,152.00The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements. On the supplier side, smaller vendors rely […]May 1, 2003$1,875.00 – $3,750.00Each year in the United States, more than 500,000 people with coronary artery disease are treated with percutaneous transluminal coronary angioplasty (PTCA). Unfortunately, restenosis occurs within three to six months in 40% to 50% of PTCA patients due to either thrombosis or abnormal tissue growth. As a result, restenosis constitutes the major limitation to the […]April 1, 2003$995.00 – $5,990.00Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the […]July 1, 2000